NASDAQ:CRCT • US22658D1000
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CRICUT INC - CLASS A (CRCT).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-14 | Goldman Sachs | Maintains | Sell -> Sell |
| 2025-10-17 | Goldman Sachs | Maintains | Sell -> Sell |
| 2025-04-14 | Citigroup | Downgrade | Neutral -> Sell |
| 2025-03-06 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2024-11-06 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-03-07 | Barclays | Maintains | Underweight -> Underweight |
| 2024-03-06 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-03-06 | Citigroup | Maintains | Neutral -> Neutral |
| 2023-12-13 | Goldman Sachs | Initiate | Neutral |
| 2023-11-08 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2023-08-28 | Citigroup | Initiate | Neutral |
| 2023-05-11 | Barclays | Maintains | Underweight -> Underweight |
| 2023-03-09 | Barclays | Maintains | Underweight |
| 2023-03-08 | Citigroup | Maintains | Neutral |
| 2022-10-17 | Morgan Stanley | Maintains | Underweight |
| 2022-08-11 | Barclays | Maintains | Underweight |
| 2022-08-10 | Morgan Stanley | Maintains | Underweight |
| 2022-07-14 | Citigroup | Maintains | Neutral |
| 2022-06-15 | Morgan Stanley | Maintains | Underweight |
| 2022-05-17 | Morgan Stanley | Maintains | Underweight |
| 2022-05-12 | Goldman Sachs | Maintains | Neutral |
| 2022-05-11 | Citigroup | Maintains | Neutral |
| 2022-03-10 | Barclays | Maintains | Underweight |
| 2022-03-09 | Morgan Stanley | Maintains | Underweight |
| 2021-12-22 | Citigroup | Maintains | Neutral |
| 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 765.147M -13.67% | 712.538M -6.88% | 708.78M -0.53% | 709.55M 0.11% | 715.37M 0.82% | |
| EBITDA YoY % growth | 109.977M 0.07% | 106.516M -3.15% | 121.072M 13.67% | 82.499M -31.86% | 94.956M 15.10% | |
| EBIT YoY % growth | 79.938M -3.57% | 77.51M -3.04% | 96.633M 24.67% | 42.278M -56.25% | 52.342M 23.80% | |
| Operating Margin | 10.45% | 10.88% | 13.63% | 5.96% | 7.32% | |
| EPS YoY % growth | 0.24 -14.29% | 0.29 20.83% | 0.36 24.14% | 0.17 -52.68% | 0.20 19.76% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 0.04 -62.91% | 0.06 -45.75% | 0.05 -49.77% | 0.01 -87.25% |
| Revenue Q2Q % growth | 163.67M 0.64% | 170.38M -1.01% | 176.65M 3.65% | 205.12M 0.75% |
| EBITDA Q2Q % growth | 22.371M -36.89% | 26.837M -36.39% | 22.855M -43.96% | 306K -99.21% |
| EBIT Q2Q % growth | 9.773M -66.69% | 16.531M -45.09% | 13.257M -41.47% | -5.406M -137.19% |
All data in USD
8 analysts have analysed CRCT and the average price target is 3.4 USD. This implies a price decrease of -16.05% is expected in the next year compared to the current price of 4.05.
CRICUT INC - CLASS A (CRCT) will report earnings on 2026-05-04.
The consensus EPS estimate for the next earnings of CRICUT INC - CLASS A (CRCT) is 0.04 USD and the consensus revenue estimate is 163.67M USD.